LifeMD, Inc.: updates and filings

LFMDNASDAQHealthcare · Services-Offices & Clinics of Doctors of Medicine

Price

$1.79

November 17, 2026Market cap $86M

What Ploutos Investor adds for LifeMD

Part of Ploutos Investor, €9.99 a month

See the plans
  • The full history: 14 fiscal years, from 2012
  • The estimated fair value, with its range and its certainty
  • The full analysis, 18 a month
  • More questions to the chat on its filings
  • Excel with every year
  • An email when it reports, changes its dividend or an officer buys

Sign in with a free account to see the last 5 fiscal years.

What comes next, and what happened

Its next results and latest dividend, and the filings that told of something: results, deals, people, debt. In plain words, each linked to the filing.

Next results

in 79 daysAround Feb 5, 2027 · for Q4 2026

last Aug 5, 2026next Feb 5, 2027

An estimate from when it has reported before, and the timing has varied a little. The company announces the date itself.

Its SEC filings

What it has filed lately, newest first, linked to the document itself.

Mar 10, 2026 latest annualNov 12, 2026 latest quarterly
  • Nov 12, 2026Quarterly reportfor the period to Sep 30, 2026
    Form10-Q
  • Nov 12, 2026Material agreement entered, results of operations, new material financial obligation, unregistered sale of shares, Regulation FD disclosure
    Form8-K
  • Nov 9, 2026Notice that the quarterly report will be filed late
    FormNT 10-Q
  • Oct 7, 2026Over-5% holder statement (passive) (amendment)
    FormSCHEDULE 13G/A
  • Sep 25, 2026Shares registered for employees
    FormS-8
  • Sep 15, 2026Regulation FD disclosure
    Form8-K
  • Aug 5, 2026Quarterly reportfor the period to Jun 30, 2026
    Form10-Q
  • Aug 5, 2026Results of operations, Regulation FD disclosure
    Form8-K
  • Jul 8, 2026Over-5% holder statement (passive)
    FormSCHEDULE 13G
  • Jun 22, 2026Regulation FD disclosure
    Form8-K
  • May 6, 2026Quarterly reportfor the period to Mar 31, 2026
    Form10-Q
  • May 6, 2026Results of operations, Regulation FD disclosure
    Form8-K
  • Apr 30, 2026Annual report to shareholdersfor the period to Dec 31, 2025
    FormARS
  • Apr 30, 2026Additional annual meeting material
    FormDEFA14A
  • Apr 30, 2026Additional annual meeting material
    FormDEFA14A
  • Apr 30, 2026Annual meeting proxy statement
    FormDEF 14A
  • Apr 1, 2026Shares registered for employees
    FormS-8
  • Mar 18, 2026Officer or director change, other material events
    Form8-K
  • Mar 10, 2026Annual reportfor the period to Dec 31, 2025
    Form10-K
  • Mar 9, 2026Results of operations, Regulation FD disclosure
    Form8-K
  • Jan 6, 2026Material agreement entered, new material financial obligation, Regulation FD disclosure
    Form8-K
  • Nov 17, 2025Quarterly reportfor the period to Sep 30, 2025
    Form10-Q
  • Nov 17, 2025Results of operations
    Form8-K
  • Nov 12, 2025Notice that the quarterly report will be filed late
    FormNT 10-Q
  • Nov 5, 2025Regulation FD disclosure
    Form8-K

From the company's record at the SEC (EDGAR). The topics of each 8-K are the item codes the company itself filed. Its whole record at the SEC, since May 17, 2012.

The full analysis

What do LifeMD's filings show?

The filings are where every one of LifeMD's figures comes from. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.

  • A fair value range built from the filings
  • Earnings quality, debt and red flags
  • Insider and institutional moves
  • The case for and the case against

All filings on EDGAR

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.